Tumor-targeted nanoparticles improve the therapeutic index of BCL2 and MCL1 dual inhibition is a research paper published in Blood (2020). On theSindex it has a DataRank of 0. It has been cited 36 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NICHD NIH HHS
Grant: DP2 HD075698
NCI NIH HHS
Grant: T32 CA062948
NCI NIH HHS
Grant: P50 CA192937
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: R01 CA215719
Fields of Study
MeSH Terms